| Product NDC: | 52054-550 |
| Proprietary Name: | ALBENZA |
| Non Proprietary Name: | albendazole |
| Active Ingredient(s): | 200 mg/1 & nbsp; albendazole |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52054-550 |
| Labeler Name: | Amedra Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020666 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20111222 |
| Package NDC: | 52054-550-28 |
| Package Description: | 28 TABLET, FILM COATED in 1 BOTTLE (52054-550-28) |
| NDC Code | 52054-550-28 |
| Proprietary Name | ALBENZA |
| Package Description | 28 TABLET, FILM COATED in 1 BOTTLE (52054-550-28) |
| Product NDC | 52054-550 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | albendazole |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20111222 |
| Marketing Category Name | NDA |
| Labeler Name | Amedra Pharmaceuticals |
| Substance Name | ALBENDAZOLE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antihelminthic [EPC] |